Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07613307
What this trial is testing

Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

Who this might be right for
Diabetes Mellitus, Type 2Diabetes MelletusGlucose Metabolism Disorders+13 more
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Study completedNCT06854952
What this trial is testing

A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity

Who this might be right for
Overweight or Obesity
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 167
Post-approval studies (Phase 4)Study completedNCT07374445
What this trial is testing

Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery

Who this might be right for
ObesityWeight LossBariatric Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07760948
What this trial is testing

HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)SarcopeniaObesity+2 more
Vanderbilt University Medical Center 90
Large-scale testing (Phase 3)Study completedNCT00905255
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 69
Early research (Phase 1)Not Yet RecruitingNCT07758231
What this trial is testing

Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics

Who this might be right for
GLP-1Alcohol
University of Wisconsin, Madison 5
Not applicableNot Yet RecruitingNCT07720466
What this trial is testing

Salivary Function and Dental Changes During GLP-1 Therapy

Who this might be right for
ObesityDental ErosionSaliva Collection+1 more
Bilecik Seyh Edebali Universitesi 40
Not applicableUnknownNCT04034524
What this trial is testing

Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Brigham and Women's Hospital 20,000
Post-approval studies (Phase 4)Enrolling By InvitationNCT07117240
What this trial is testing

Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes

Who this might be right for
Steroid-Induced DiabetesSteroid-Induced HyperglycemiaDiabetes
Medical University of Warsaw 100
Testing effectiveness (Phase 2)WithdrawnNCT02472717
What this trial is testing

Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

Who this might be right for
Psoriatic ArthritisPsoriasisImpaired Glucose Tolerance+1 more
University Health Network, Toronto
Large-scale testing (Phase 3)Study completedNCT03115424
What this trial is testing

Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy

Who this might be right for
Obesity
Mayo Clinic 46
Large-scale testing (Phase 3)Not Yet RecruitingNCT07829198
What this trial is testing

Efficacy of Tirzepatide for Weight Management in Patients With Suboptimal Weight Loss After Bariatric Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Who this might be right for
Obesity
Universidade do Porto 70
Post-approval studies (Phase 4)Not Yet RecruitingNCT07462663
What this trial is testing

SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Cancer Stage IAtypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I+6 more
Hospital Universitari de Bellvitge 80
Not applicableStudy completedNCT07465926
What this trial is testing

Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3

Who this might be right for
Cardiovascular-kidney-metabolic SyndromeCardiovascular Disease Risk FactorKidney Disease+2 more
Chung Shan Medical University 451,036
Not applicableUnknownNCT06513715
What this trial is testing

Activity of Bioactive Natural Compounds as Potential Agonists of GLP1R

Who this might be right for
ObesityOverweight
Universidad Católica San Antonio de Murcia 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT07446998
What this trial is testing

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Who this might be right for
Obesity & OverweightMobility DisabilityHOMA-IR
Veru Inc. 239
Early research (Phase 1)Study completedNCT01373450
What this trial is testing

Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 12
Not applicableLooking for participantsNCT06666049
What this trial is testing

Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric)

Who this might be right for
Aspiration Pneumonia
Clinica Universidad de Navarra, Universidad de Navarra 39
Large-scale testing (Phase 3)Looking for participantsNCT07284511
What this trial is testing

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

Who this might be right for
Type 1 DiabetesType 1 Diabetes MellitusT1D+2 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 105
Large-scale testing (Phase 3)Looking for participantsNCT07775404
What this trial is testing

Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

Who this might be right for
ObesityOverweight
AstraZeneca 351
Next Page